Filing Details
- Accession Number:
- 0001140361-14-041531
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-13 14:48:31
- Reporting Period:
- 2014-11-12
- Filing Date:
- 2014-11-13
- Accepted Time:
- 2014-11-13 14:48:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1587774 | Blasius Eric Risser | 9640 Medical Center Drive Rockville MD 20850 | Vp, Business Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-12 | 10,000 | $0.94 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-12 | 15,000 | $23.00 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2014-11-13 | 10,000 | $0.94 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-13 | 10,000 | $25.00 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-12 | 10,000 | $0.00 | 10,000 | $0.94 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-13 | 10,000 | $0.00 | 10,000 | $0.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,836 | 2009-09-24 | 2019-03-23 | No | 4 | M | Direct |
| 40,836 | 2009-09-24 | 2019-03-23 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 31, 2014.
- The price reported in Column 4 is a weighted average price.
Billionaire Hedge Funds
